Request Early Access

Our collaboration with Medicines for Malaria Venture helped reduce a known CYP450 liability in a lead compound, with results validated in the lab.

Comparing different molecular generators from LLMs to REINVENT

deepmirror has successfully secured an Innovate UK Flexible, Agile, Sustainable, Scalable Technologies (FASS) grant.

In drug discovery, where intellectual property and confidential data are paramount, ensuring robust security measures is a top priority...

How a European biotech used deepmirror to find novel scaffolds for first-in-class oncology drug candidates in just 2 weeks.

Is there a single AI model that can accurately predict whether a molecule would be a good drug against a disease?

Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic drug discovery

DeepMirror has successfully secured UKRI’s Biomedical Catalyst grant in collaboration with Nuclera.

Kinases are frequently dysregulated in disease and are an interesting yet challenging target against which to develop drugs. In this...